Cancer News and Research

Latest Cancer News and Research

'Twist' gene plays a key role in the development of breast cancer

Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.

5 Dec 2009

Dana-Farber Cancer Institute receives 2009 MMRC Center of the Year Award

The Multiple Myeloma Research Consortium (MMRC) today announced that it has awarded the Dana-Farber Cancer Institute, and its clinical researchers, Kenneth Anderson, MD, and Paul Richardson, MD, with the 2009 MMRC Center of the Year Award.

5 Dec 2009

Statins may help protect stem cell transplant patients from GVHD

Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD. The findings are reported in the Nov. 4 first edition of the journal Blood.

5 Dec 2009

NCI awards $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center

The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.

5 Dec 2009

DTI helps identify distorted nerve fiber bundles around brain tumors in thalamic JPA children

A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.

5 Dec 2009

Scientists report cervarix vaccine offers protection against cervical cancer

The Cervarix vaccine provides protection against two types of human papillomavirus (HPV) for more than six years, US scientists have reported.

5 Dec 2009

Gamma Labs sponsors the Charles Evans PCF Pro/Am Tour

On December 1, 2009 at the annual Prostate Cancer Foundation Annual Dinner, the organization acknowledged its sponsors and provided insight of the year’s events and milestones. Gamma Labs, a leading nutritional supplement company, was recognized as one of the organization’s sponsors. Gamma Labs is pleased to announce today plans to continue support of this organization. Gamma Labs serves as a sponsor for the Charles Evans PCF Pro/Am Tour, an annual event that benefits the Prostate Cancer Foundation.

5 Dec 2009

Benign tumors in children can be augmented with Diffusion Tensor Imaging

5 Dec 2009

Thermography, an ideal screening tool for breast cancer

Thermographic Diagnostic Imaging (TDI), part of a Health & Wellness Center in Marlton, New Jersey continues to provide superior quality infrared imaging of the breast, neuromuscular system, thyroid, dental, TMJ and sinus regions to assist in the early diagnosis of problems associated with these areas.

4 Dec 2009

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

Fluxion Biosciences announced today that it has expanded its sales and service network into Asia. The company signed a distribution agreement for its BioFlux™ line with Korea-based DI Biotech. A second agreement with Novel Science covers sales of both the BioFlux and IonFlux™ platforms in Japan. Fluxion has also sold its first BioFlux 1000 system into China.

From Fluxion Biosciences 4 Dec 2009

PLUS Diagnostics expands its specialty anatomic pathology services

PLUS Diagnostics announced today that it has expanded its specialty anatomic pathology services with the launch of a national hematology/oncology offering. The new service completes the company's expansion from a regional laboratory to a leading national anatomic pathology company offering diagnostic services across a full range of specialties including gastroenterology, urology and now hematology/oncology.

4 Dec 2009

Pre-clinical study data of Stemline Therapeutics' IL-3R targeting agents to be presented at the ASH meeting

Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.

4 Dec 2009

ZIOPHARM Oncology prices public offering of 15,484,000 shares of its common stock

ZIOPHARM Oncology, Inc. announced the pricing of its previously announced underwritten public offering of 15,484,000 shares of its common stock and warrants to purchase 7,742,000 shares of its common stock at a public offering price of $3.10 per unit.

4 Dec 2009

Senate bill moves forward, amendment ensures coverage for women's preventive care

Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."

4 Dec 2009

BUSM researchers report an inverse association between dairy intake and fibroid risk

Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Center found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's Health Study, appears in the current issue of the American Journal of Epidemiology.

4 Dec 2009

Silicon to transport drugs in the human body: a novel drug delivery method under development

Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).

4 Dec 2009

Results from Phase III pivotal study of FIRMAGON presented

Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurrence rate in a Phase III pivotal study of FIRMAGON® (monthly degarelix for injection) or monthly leuprolide in prostate cancer patients during the first year of treatment.

4 Dec 2009

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent acquisition of Wyeth, focusing on the needs of multiple breast cancer patient populations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) being held December 9 – 13.

4 Dec 2009

Preclinical data of Curis' HSP 90 inhibitor published

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that preclinical data related to CUDC-305, the company’s Heat Shock Protein (HSP) 90 inhibitor, was published online this week in Molecular Cancer Therapeutics.

4 Dec 2009

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

4 Dec 2009

Cancer News and Research

Latest Cancer News and Research

'Twist' gene plays a key role in the development of breast cancer

Dana-Farber Cancer Institute receives 2009 MMRC Center of the Year Award

Statins may help protect stem cell transplant patients from GVHD

NCI awards $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center

DTI helps identify distorted nerve fiber bundles around brain tumors in thalamic JPA children

Scientists report cervarix vaccine offers protection against cervical cancer

Gamma Labs sponsors the Charles Evans PCF Pro/Am Tour

Benign tumors in children can be augmented with Diffusion Tensor Imaging

Thermography, an ideal screening tool for breast cancer

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

PLUS Diagnostics expands its specialty anatomic pathology services

Pre-clinical study data of Stemline Therapeutics' IL-3R targeting agents to be presented at the ASH meeting

ZIOPHARM Oncology prices public offering of 15,484,000 shares of its common stock

Senate bill moves forward, amendment ensures coverage for women's preventive care

BUSM researchers report an inverse association between dairy intake and fibroid risk

Silicon to transport drugs in the human body: a novel drug delivery method under development

Results from Phase III pivotal study of FIRMAGON presented

Pfizer to present study findings from its expanded breast cancer portfolio

Preclinical data of Curis' HSP 90 inhibitor published

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Cancer Research - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in